NCT06145854Active, not recruiting
Cisgender Female Patients Who Start on Long Acting Cabotegravir for PrEP
Real World Clinical Outcomes in Cisgender Female Patients Who Start on Long Acting Cabotegravir for PrEP: An Observational, Multisite Prospective 2 Year Study in the Southern U.S.
Source: ClinicalTrials.gov · Last updated 3 Nov 2025
Brief summary (registry, in English)
Oral PrEP regimens (FTC/TDF have been the mainstay of HIV prevention however patients now have more options for HIV prevention. In addition to oral PrEP regimens, the FDA approved the use of long acting Cabotegravir (CAB-LA) as the first long-acting medication for HIV prevention. This study will evaluate real world clinical outcomes of cisgender female patients who start CAB-LA for PrEP.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 17 Nov 2023
- Start date
- 2 Jan 2024
- Primary completion date
- 30 Oct 2026
- Lead sponsor
- Midway Specialty Care Center
- Diseases
- HIV
- NCT number
- NCT06145854
What you commit to
- Study type: Observational
- Planned participants: 100
- From 2 Jan 2024 to the primary completion date, 30 Oct 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Evidence of Hepatitis B Infection
- History or presence of allergies to cabotegravir or its components
Other
- Transgender females or males
- Cisgender males
- Cisgender female who is actively breastfeeding
- Severe hepatotoxicity
Who the study is looking for
- Cisgender females, ages 18 years and older
- Negative HIV test at baseline
- Negative Pregnancy test at baseline
- Weigh at least 35 kilograms
- Already Prescribed CAB-LA (Apretude)
Age in the registry: 18 years to - · Sex: Female
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Midway Specialty Care Center Coordinator of this site? Confirm its status | Orlando | United States | Unknown status |
| Midway Specialty Care Center Coordinator of this site? Confirm its status | Temple Terrace | United States | Unknown status |
| Midway Specialty Care Center Coordinator of this site? Confirm its status | West Palm Beach | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.